Similar articles

• [Hyperlipoproteinemia].

  Meinders AE. Meinders AE. Ned Tijdschr Geneeskd. 1979 Mar 14;123(15):617-28. Ned Tijdschr Geneeskd. 1979. PMID: 219378 Dutch. No abstract available.
• Plasma lipoproteins: recent developments.

  Gotto AM Jr, Jackson RL. Gotto AM Jr, et al. Adv Exp Med Biol. 1977;82:15-33. doi: 10.1007/978-1-4613-4220-5_4. Adv Exp Med Biol. 1977. PMID: 200086 Review. No abstract available.
• Lipid lowering drugs and hyperlipidaemia.

  Levy RI, Rifking BM. Levy RI, et al. Drugs. 1973;6(1):12-45. doi: 10.2165/00003495-197306010-00003. Drugs. 1973. PMID: 4361281 Review. No abstract available.
• Mechanisms of hyperlipoproteinemia.

  Havel RJ. Havel RJ. Adv Exp Med Biol. 1972;26(0):57-70. doi: 10.1007/978-1-4684-7547-0_4. Adv Exp Med Biol. 1972. PMID: 4370189 Review. No abstract available.
• Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

  Brown MS, Dana SE, Goldstein JL. Brown MS, et al. J Biol Chem. 1974 Feb 10;249(3):789-96. J Biol Chem. 1974. PMID: 4359767 No abstract available.